Ignite Creation Date:
2024-05-06 @ 11:06 AM
Last Modification Date:
2024-10-26 @ 12:40 PM
Study NCT ID:
NCT03435601
Status:
UNKNOWN
Last Update Posted:
2020-03-02
First Post:
2018-01-31
Brief Title:
A Study to Target the Type I IFN Receptor by Administrating Anifrolumab in RA Patients With a High IFN Signature TarIFNiRA
Sponsor:
Josef Smolen Univ Prof Dr
Organization:
Medical University of Vienna
Organization Data
Organization:
Medical University of Vienna
Class:
OTHER
Study ID:
TarIFNiRA
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Josef Smolen Univ Prof Dr
Lead Sponsor Class:
OTHER
Responsible Party:
Josef Smolen Univ Prof Dr
Responsible Party Title:
Sponsor-Investigator
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Medical University of Vienna
Old Name:
None
Old Organization:
None